Charles Gore

🌍 Exciting news! The Government of Flanders (@vlaamseoverheid) has allocated €2⃣ million to boost health security in #Africa with MPP & @WHO. ✅This is to strengthen local #vaccine and #therapeutic manufacturing for better #pandemic preparedness. 🔗bit.ly/4gGNi3D #GlobalHealth #HealthEquity #Flanders

🏭Delighted to be attending 2nd African Manufacturing Forum for AU Member States in #Cairo🇪🇬. We fully support regional manufacturing of vaccines & therapeutics on the continent 💉 @gavi @AfricaCDC @CharlieGore #vaccines #AccessToHealth

🌍🎗️ This #WorldCancerDay, be inspired by Kennedy Odhiambo's journey in #Kenya 🇰🇪through #NasopharyngealCancer. 🗣️His story highlights the urgent need for accessible and affordable cancer treatments. 📑Read how Kennedy's determination and community support helped him overcome immense challenges. 📖✨bit.ly/40Lsm5o #CancerAwareness #NasopharyngealCancer #HealthForAll #UnitedByUnique

🌍🎗️ This #WorldCancerDay, join us in raising awareness about #ChronicMyeloidLeukaemia and the importance of accessible treatments. 📹Watch our exclusive interview with Prof. Zeba Aziz as she discusses the impact of #nilotinib and the efforts to make life-saving medicines available to all. 📺✨Don't miss out! 🔗youtu.be/UKmvGMnQHT0?si… #CancerAwareness #HealthForAll #UnitedByUnique

🌟 New Video Alert ahead of #WorldChildrensDay ! 🌟 💻Discover the story of the Nyumbani Children's Home, a sanctuary for babies and children with #HIV in #Kenya🇰🇪. Nyumbani, meaning "home" in #Kiswahili, has transformed from a hospice into a loving home for approximately 1⃣0⃣0⃣ orphans and vulnerable children. 📽️In this video, we explore the incredible advancements in paediatric HIV medicines, making it easier to provide care for these young ones. 🤓Learn about the upcoming rollout of paediatric #ALD, a fixed-dose combination for children living with HIV, and see firsthand the impact of access to adapted paediatric formulations in LMICs. @NyumbaniUSA @GAP_f_Network #BetterMeds4Kids 🔗youtu.be/_xPID_ZST1Y?si…

💉New advancements to prevent #RSV infection bring hope on this #WorldPneumoniaDay ✨ ! 💪🏽Maternal vaccination and monoclonal antibodies like #nirsevimab and #clesrovimab offer promising protection against RSV. 🇺🇳@WHO’s SAGE recommended that all countries introduce passive immunisation for the prevention of severe RSV disease in young infants👶🏽🐣. ✨At MPP, we believe in the power of voluntary licensing and technology transfer to make life-saving RSV therapies accessible and affordable especially in low- and middle-income countries🌍 where the massive burden of RSV is concentrated. ➡️Read the message from MPP Executive Director @CharlieGore and spread the word! 🔗 bit.ly/40FGL4G @Stop_Pneumonia @wellcometrust @IAVI @unitaid @ReSViNET #BetterMeds4Kids #RSVPrevention #GlobalHealth

📢On this #WorldHepatitisDay, let's amplify the urgent message from @CharlieGore: The fight against #hepatitis is at a critical juncture. Despite having the tools to prevent and treat hepatitis B and C, mortality rates are rising, and we are veering off course from the 2030 target. ✊🏽It's #TimeForAction, not complacency. Read his message > bit.ly/3Sl4nGU

📸 A big shout-out to everyone who visited our MPP/@UNITAID booth (#904) at #AIDS2024! Your support for the #IAmPartOfTheDTGStory campaign has been overwhelming. 🥰 There's still time to be part of the story! Come get your photo taken and join the movement. Together, we're making history. 🌍✨ medicinespatentpool.org/partners/stori… #GlobalHealth #MakeADifference #DTGDecade

"We need to grant generic licensing through the UN backed Medicines Patent Pool, and make generics available for all of Africa, Asia and Latin America." - @UNAIDS Executive Director @Winnie_Byanyima 🇺🇳 #AIDS2024

🥰MPP is excited to be #AIDS2024👇 ✅ Our team is speaking in a number of sessions of the official programme ✅ We are also participating in many events organised in the Exhibition Area and at the Global Village ✅ MPP & @UNITAID are teaming up at booth #904 in the Exhibition Area. Come and meet us there! Check out MPP full programme 👉 bit.ly/3zIe0sE

We're excited to be at #AIDS2024 in a few days! 🎉 ✅Our team will be speaking in a number of sessions of the official programme ✅We will also participate in many events organised in the Exhibition Area and at the Global Village ✅MPP & @UNITAID are teaming up at booth #904 in the Exhibition Area. Come and meet us there! Check out MPP full programme at #AIDS2024 👉🏽bit.ly/3zIe0sE

Following the MPP-ViiV agreement on #dolutegravir in late 2020, we're pleased to announce progress in the fight against #HIV in Azerbaijan🇦🇿, Belarus🇧🇾, Kazakhstan🇰🇿 & Malaysia🇲🇾👇 ✅ In Belarus & Kazakhstan, the volumes of DTG procured by national HIV programmes can cover 78% and 86% of people on #ART respectively. ✅ Azerbaijan is making strides to reach 65%of people on ART with DTG treatments this year🎉 ✅Malaysia is planning to accelerate the transition to TLD starting from 2025. These achievements were made possible by price reductions ↘️  of over 90% and are a result of the dedication of many, incl communities, healthcare professionals & governments. Read our statement 👉 bit.ly/3VZFnak #GlobalHealth #Access2Meds

🌐 Discover the New #MedsPaL: Your trusted source for #EssentialMedicine💊🫗 and #Vaccine💉 patent information just got an upgrade! 🚀 Explore the latest features like 👇🏾 ✅saved searches 💾, ✅email notifications 📧, and ✅enhanced mobile compatibility 📱. Stay ahead in the IP landscape with medspal.org

🗞️#PressRelease | 🎉The Medicines Patent Pool Unveils New Version🚀 of #MedsPaL 💻for Streamlined Access to #GlobalHealth #IntellectualProperty Information. Access our PR 👉🏾bit.ly/3UNSpqO 🔎#MedsPaL is a free resource that provides crucial information on the intellectual property status of ✅patented essential medicines, ✅COVID-19 vaccines, and ✅long-acting platform technologies, with a particular focus on low- and middle-income countries🌍.

As we reflect on a decade of collaboration w/ ViiV Healthcare, we are proud to see that #PublicHealth-oriented voluntary licensing has had tangible impact in the lives of the people we serve, enabling access to affordable versions of innovative #HIV treatments in LMICs.

🎙️@CharlieGore du MPP explique ce qu’est le programme de transfert de technologies à ARN messager qui comprend 6️⃣ partenaires en #Afrique. ✅accès équitable aux technologies à ARNm ✅Valeur ajoutée et partage des actifs de propriété intellectuelle ✅Capacités de production durables de vaccins à ARNm 🙌🏽 La production régionale en Afrique est essentielle pour l’autonomie de l’Afrique medicinespatentpool.org/fr/ce-que-nous…

La session “renforcer l’écosystème de la production régionale et locale en #Afrique de l’Ouest et Centrale” commence à l’@IFCameroun. ✅Nous allons aborder le programme de transfer de technologies #ARNm avec 6️⃣partenaires en Afrique ✅Nous discuterons aussi des initiatives d’@UNITAID pour promouvoir la production régionale ✅ Nous explorerons comment le #Cameroun peut devenir un modèle dans ce domaine

#AFRAVIH2024 au Symposium d’@UNITAID 🎙️Le Directeur exécutif du MPP @CharlieGore explique comment le modèle du MPP, qui a été créé par @UNITAID, participe à la réponse contre le #VIH aux côtés de nombreux autres partenaires. 🤝Le MPP a notamment signé une licence avec @ViiVHC pour le #dolutegravir ce qui permet un accès abordable de ce produit, recommandé en 1ere intention par @WHO, dans les pays à revenus faible et intermédiaire. 👉🏽medicinespatentpool.org

Vous êtes à #AFRAVIH2024 au #Cameroun 🇨🇲? Notre directeur exécutif @CharlieGore participera au symposium d’@UNITAID cet après-midi à 15h30, salle 4/E. Il expliquera comment le Medicines Patent Pool a contribué à la lutte contre le #VIH et ses co-infections. Venez nombreux !

Earlier today MPP ED @CharlieGore participated in a panel discussion on "Elimination of viral hepatitis: What still needs to be done to make it real?" during the #WorldHepatitisSummit 👇🏾 ✅Access to affordable #hepatitis testing and treatment should be available to all, including in low- and middle-income countries ✅if countries do not procure medicines at the access price, the price may not be guaranteed anymore > investment cases are needed! ✅MPP welcomes the newly released @WHO 2024 Global #Hepatitis report > bit.ly/43Pzpeq